Form 4 for PSA Public Storage
Accepted 2022-12-23 00:00:00 ET · period of report 2022-12-22 · accession 0001567619-22-021985 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-23 | 2022-12-22 | PSA | GUSTAVSON TAMARA HUGHES | Dir, 10% | M - OptEx | $196.85 | +36.1K | 14.15M | +0.3% | +$7.11M |
| DM | 2022-12-23 | 2022-12-22 | PSA | GUSTAVSON TAMARA HUGHES | Dir, 10% | M - OptEx | $0.00 | -36.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-22 | M | A | 5,163 | $250.29 | 14,135,128 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-22 | M | A | 5,163 | $211.30 | 14,150,617 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-22 | M | A | 5,163 | $159.40 | 14,119,639 | D | — | — | |
| 4 | Common | Common Stock | 2022-12-22 | M | A | 5,163 | $170.60 | 14,124,802 | D | — | — | |
| 5 | Common | Common Stock | 2022-12-22 | M | A | 5,163 | $181.95 | 14,129,965 | D | — | — | |
| 6 | Common | Common Stock | 2022-12-22 | M | A | 5,163 | $216.83 | 14,140,291 | D | — | — | |
| 7 | Common | Common Stock | 2022-12-22 | M | A | 5,163 | $187.57 | 14,145,454 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-12-22 | M | D | 5,163 | $0.00 | 0 | D | $181.95 · 2016-04-30 to 2025-04-30 | 5,163 Common Stock | (F5) Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. (F8) This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $187.91, but, pursuant to anti-dilution provisions of PSA's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-12-22 | M | D | 5,163 | $0.00 | 0 | D | $159.40 · 2014-05-09 to 2023-05-09 | 5,163 Common Stock | (F5) Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. (F6) This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $164.62, but, pursuant to anti-dilution provisions of PSA's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-12-22 | M | D | 5,163 | $0.00 | 0 | D | $170.60 · 2015-05-01 to 2024-05-01 | 5,163 Common Stock | (F5) Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. (F7) This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $176.19, but, pursuant to anti-dilution provisions of PSA's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
| 11 | Derivative | Stock Option (Right to Buy) | 2022-12-22 | M | D | 5,163 | $0.00 | 0 | D | $211.30 · 2020-04-24 to 2029-04-24 | 5,163 Common Stock | (F10) Stock option granted pursuant to the 2016 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. (F13) This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $218.22, but, pursuant to anti-dilution provisions of PSA's 2016 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
| 12 | Derivative | Stock Option (Right to Buy) | 2022-12-22 | M | D | 5,163 | $0.00 | 0 | D | $250.29 · 2017-04-25 to 2026-04-25 | 5,163 Common Stock | (F5) Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. (F9) This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $258.49, but, pursuant to anti-dilution provisions of PSA's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
| 13 | Derivative | Stock Option (Right to Buy) | 2022-12-22 | M | D | 5,163 | $0.00 | 0 | D | $216.83 · 2018-04-26 to 2027-04-26 | 5,163 Common Stock | (F10) Stock option granted pursuant to the 2016 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. (F11) This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $223.93, but, pursuant to anti-dilution provisions of PSA's 2016 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
| 14 | Derivative | Stock Option (Right to Buy) | 2022-12-22 | M | D | 5,163 | $0.00 | 0 | D | $187.57 · 2019-04-25 to 2028-04-25 | 5,163 Common Stock | (F10) Stock option granted pursuant to the 2016 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. (F12) This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $193.71, but, pursuant to anti-dilution provisions of PSA's 2016 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |